Science

How Hantavirus Kills

MedCram
MedCram•May 7, 2026

Why It Matters

Understanding hantavirus’s endothelial attack guides early ICU triage and informs therapeutic strategies, potentially lowering the high fatality rate of this emerging zoonotic threat.

Key Takeaways

  • •Andes hantavirus infects lung endothelial cells, causing leaky capillaries.
  • •Suppressed interferon response allows virus to spread before symptoms appear.
  • •Leaky vessels lead to non‑cardiogenic pulmonary edema and hypovolemic shock.
  • •Early ICU care, ventilation, and ECMO dramatically improve survival rates.
  • •Targeting interferon pathways and viral entry receptors offers therapeutic potential.

Summary

The video explains how the Andes strain of hantavirus kills by attacking the pulmonary endothelium, producing a mortality rate around 40 percent. It contrasts this New World virus with the milder Old World strains and walks through the seven‑stage clinical progression from flu‑like prodrome to catastrophic leaky‑capillary syndrome.

Key mechanisms include viral suppression of interferon, allowing unchecked replication in endothelial cells, and the disruption of tight‑junction proteins via VEGF signaling, β3‑integrin and protocadherin‑1 pathways. The resulting capillary leak floods alveoli with fluid while depleting intravascular volume, causing non‑cardiogenic pulmonary edema, hypovolemia, and eventual cardiac failure.

Clinical hallmarks are bilateral infiltrates on chest X‑ray and rapid hypoxemia. Early intensive‑care interventions—mechanical ventilation to re‑inflate alveoli and ECMO to oxygenate blood—cut mortality from roughly 38 % to far lower levels, though ECMO capacity remains limited. The presenter emphasizes that patients who mount a robust interferon response survive at higher rates.

The take‑away for clinicians is to recognize the flu‑like prodrome, initiate aggressive supportive care before the leaky‑pipe phase, and consider therapies that boost interferon or block viral entry receptors. Ongoing research into antivirals and immunomodulators could further reduce deaths in future outbreaks.

Original Description

Roger Seheult, MD of MedCram explains the mechanism by which hantavirus kills. See all Dr. Seheult's videos at: https://www.medcram.com/
(This video was recorded on May 7th, 2026)
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Clinician Brief: Hantavirus Pulmonary Syndrome (HPS) (CDC) | https://www.cdc.gov/hantavirus/hcp/clinical-overview/hps.html
Protocadherin-1 is essential for cell entry by New World hantaviruses (Nature) | https://pmc.ncbi.nlm.nih.gov/articles/PMC6556216/
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
https://www.youtube.com/user/MEDCRAMvideos?Exposure to a more unhealthy diet impacts sleep microstructure during normal sleep and recovery sleep: A randomized trial=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Video Produced by Kyle Allred
Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC
FOLLOW US ON SOCIAL MEDIA:
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#hanta #virus #outbreak

Comments

Want to join the conversation?

Loading comments...